ULTA Ulta Beauty Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 72
Relative Strength: Rel. Strength: 73
Relative Valuation: Rel. Valuation: 66
Relative Profitability: Rel. Profitability: 76

EPS in 2025 (TTM): $26.12

Last Report Period Date: Aug 2, 2025

Currently, ULTA's 12-month EPS stands at $26.12, according to the most recent financial reports. Ulta Beauty's earnings per share in 2024 was reported at $25.44, marking a decline from $26.18 in 2023. ULTA recorded an EPS of $5.8 for the quarterly period ending on Aug 2, 2025.

ULTA earnings history

Historical annual and quarterly earnings per share (EPS) data for Ulta Beauty
EPS (TTM)
$26.12
EPS Growth YoY (Quarterly)
9%
EPS (Quarterly)
$5.8
EPS Growth (Quarterly)
-13.7%

In 2024, Ulta Beauty's earnings per share was $25.44, a decline of 2.8% from $26.18 in 2023. The quarterly earnings per share for the period ending Aug 2, 2025, was $5.8, showing a 9% increase compared to the same quarter last year. The trailing twelve months EPS for ULTA is $26.12 as of August 2025. Ulta Beauty's full-year EPS for 2023 was $26.18, a 8.3% rise compared to the previous year.

ULTA EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
9%
EPS growth YoY
-2.8%
EPS growth 3Y avg
12%
EPS growth 5Y avg
15.8%

In the past 12 months, Ulta Beauty has recorded an earnings per share growth rate of 9% (YoY, quarterly). Over an extended period, the company registered an average EPS annual growth rate of 12% per year during the last 3 years. In the last five years, the company had an average annual EPS growth of 15.8%. A ten-year view shows that ULTA has seen an average earnings per share growth of 20.3% per year.

ULTA Earnings Waterfall

Breakdown of revenue, profit and net income for Ulta Beauty

ULTA Earnings vs Peers

What are the earnings of ULTA compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
RGS Regis Corp 0.56 34.2% N/A N/A
SBH Sally Beauty Holdings Inc 7.52 -14% -11.4% -8.2%
ULTA Ulta Beauty Inc 19.98 -2.8% 12% 15.8%
CVS CVS HEALTH Corp 196.38 -43.5% -15.4% -6.4%

All data is based on quarterly TTM periods, unless otherwise specified.